跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVASA 80 MG EC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVASA 80 MG EC
Authorized
STANDARD
RIVASA 80 MG EC
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8806f5ebe5981d47
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
8806f5ebe5981d47
Drug Approval Canada Name
RIVASA 80 MG EC
Product Name
RIVASA 80 MG EC
Status
Marketed
Status Date
2019-02-01
Original Market Date
2019-02-01
Din
02485222
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.24
Atc Original
N02BA01 ACETYLSALICYLIC ACID
Atc Name
n 02 ba 01
Aig Number
0101169013
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
ACETYLSALICYLIC ACID
80 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8806f5ebe5981d47
Type
Standard
Back to Health Canada Approvals